Finance

Lists
NGVT:NYSE
Ingevity Corp
$72.74
0.00%
(0.00) 1D
Sep 28, 4:00:07 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NGVT...
Mkt. cap
2.50B
Avg. vol.
247.36K
Volume
12.00
P/E ratio
49.46
52-wk high
$79.28
52-wk low
$45.85
EPS
$1.47
Beta
1.17
Shares outstanding
34.38M
No. of employees
2K
Mkt. cap
2.50B
Avg. vol.
247.36K
Volume
12.00
P/E ratio
49.46
52-wk high
$79.28
52-wk low
$45.85
EPS
$1.47
Beta
1.17
Shares outstanding
34.38M
No. of employees
2K
News stories
From web sources and news partners
About Ingevity Corp
CEODavid H Li
Employees1.5K
Founded1964
HeadquartersNorth Charleston, South Carolina, United States
SectorSpeciality chemicals
Websiteingevity.com
Analyst ratings
Based on 1 analyst giving stock ratings to NGVT in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for NGVT in the last 3 months
Highest
Current $72.74
$85.00 (+16.85%)
Average
$85.00 (+16.85%)
Lowest
$85.00 (+16.85%)
Analyst
Recommendation
Action
Price target
Projected
Date
John McNulty
BMO Capital
Buy
Maintained
$85.00
+16.9%
07/06/2026
Michael Sison
Wells Fargo
Hold
Reiterated
$75.00
+3.1%
06/04/2026
Unknown Analyst
Jefferies
Buy
Maintained
$71.00
-2.4%
12/09/2025
Last report
Jul 30, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$1.74 / $1.28
+36.47%beat
Revenue / Est. (USD)
314.10M / 304.80M
+3.05%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
333.10M
255.10M
258.00M
314.10M
Cost of goods sold
199.20M
167.30M
141.60M
175.10M
Cost of revenue
199.20M
167.30M
141.60M
175.10M
Research and development expenses
7.00M
7.40M
6.70M
6.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44.10M
41.60M
40.70M
39.00M
Operating expense
51.10M
49.00M
47.40M
45.10M
Total operating expenses
250.30M
216.30M
189.00M
220.20M
Operating income
82.80M
38.80M
69.00M
93.90M
Other non operating income
-1.00M
-15.40M
-3.40M
-3.40M
EBT including unusual items
62.20M
-105.30M
30.20M
50.70M
EBT excluding unusual items
64.60M
6.70M
51.60M
76.00M
Income tax expense
21.40M
-26.50M
6.80M
10.90M
Effective tax rate
34.41%
25.17%
22.52%
21.50%
Other operating expenses
-
-
-
-
Net income
43.50M
-84.60M
59.80M
35.30M
Net profit margin
13.06%
-33.16%
23.18%
11.24%
Earnings per share
1.52
0.63
1.15
1.74
Interest and investment income
1.00M
-
1.20M
1.20M
Interest expense
-18.00M
-16.70M
-15.20M
-15.30M
Net interest expenses
-17.00M
-16.70M
-14.00M
-14.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
108.40M
66.60M
90.40M
114.80M
Gain or loss from assets sale
-
-
-55.60M
-7.20M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps